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Abstract
Familial exudative vitreoretinopathy (FEVR) is a rare genetic and clinically heterogeneous 
disease, due to a disorder of the vascular differentiation leading to incomplete vascularisation of the 
peripheral retina. FEVR resembles ROP changes but has clear family predisposition and no history 
of prematurity or/and oxygen therapy. atient and interfamily asymmetry of the retinal disorders is 
speci  c for FEVR. We report two cases of this rare condition.
Key words: Familial exudative vitreoretinopathy, peripheral retinal avascularization, congenital 
and hereditary vitre retinopathies
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Таблица 1. Клинична класификация на ФЕВР
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